Gesynta Pharma

Gesynta is a pharmaceutical company with highly qualified researchers from Karolinska Institutet and a team with experience in pharmaceuticals or biotech. Gesynta has patented oral mPGES-1 inhibitors that are in development for the treatment of patients with chronic inflammatory conditions, where both the anti-inflammatory effect and additional pharmacological activity are important for new innovative treatment of the indications the company focuses on.